Showing results (91-100 of 143) with videos related to
Sort By:
Pageof 15
The American Journal of Surgical Pathology|October 26, 2019
Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone PathologyMathilde Treffel, Emilie Lardenois, Frédérique Larousserie, et al.Revista Da Sociedade Brasileira De Medicina Tropical|May 30, 2019
Chicken eggs as a surveillance tool for malaria and leishmaniasis vector presenceRarissa de Oliveira E Silva, Maria Edilene Martins de Almeida, Eric Fabrício Marialva, et al.BMC Cancer|March 7, 2014
Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma groupThanh-Khoa Huynh, Pierre Meeus, Philippe Cassier, et al.Journal of Women'S Health (2002)|February 13, 2016
The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An UpdateMerina Elahi, Noha Eshera, Nkosazana Bambata, et al.Biogerontology|March 20, 2020
Expression of human HSP27 in yeast extends replicative lifespan and uncovers a hormetic responseVittoria de Lima Camandona, Rafaela Maria Rios-Anjos, Thiago Geronimo Pires Alegria, et al.Emerging Infectious Diseases|December 17, 2016
Meningitis Associated with Simultaneous Infection by Multiple Dengue Virus Serotypes in Children, BrazilPaula Eillanny Silva Marinho, Danilo Bretas de Oliveira, Talitah Michel Sanchez Candiani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma GroupJean-Yves Blay, Axel Le Cesne, Isabelle Ray-Coquard, et al.European Journal of Cancer (Oxford, England : 1990)|December 22, 2015
Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma GroupAnna Patrikidou, Julien Domont, Sylvie Chabaud, et al.European Journal of Cancer (Oxford, England : 1990)|October 22, 2021
A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)Mario Campone, Thomas Bachelot, Isabelle Treilleux, et al.Transfusion|February 15, 2017
Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNAMars Stone, Marion C Lanteri, Sonia Bakkour, et al.Pageof 15